The latest sponsored DDW Sitting Down With podcast features Lisa Moneymaker and Paul O’Donohoe of Medidata and they talk to us about decentralised clinical trials. Medidata technology has helped to bring Covid-19 vaccines and treatments to market in record timelines and the company was the first to have launched a fully end-to-end Decentralised Clinical Trials (DCT) offering. Read More
University technology and innovation is driving the UK's status in pharmaceuticals and biotechnology, according to GovGrant’s University Spinouts Report 2021. The report According to the new report, the pharmaceuticals and biotechnology sector dominates the top ten spinout companies of the last decade, ranked by valuation. Pharma and biotech companies within the top… Read More
Ferrer, a pharmaceutical company focused on neurological disorders and pulmonary vascular and interstitial lung diseases, has enrolled the first patient in its Amyotrophic Lateral Sclerosis (ALS) Deceleration with ORal Edaravone (ADORE), FNP122 Phase III clinical trial. The trial The trial will enrol about 300 patients across European countries and it will evaluate… Read More
Moderna has announced updates to its strategy to address SARS-CoV-2 variants of concern, given the emergence of the B.1.1.529 (Omicron) variant. What is Omicron? The recently described Omicron variant includes mutations seen in the Delta variant that are believed to increase transmissibility and mutations seen… Read More
The Cell and Gene Therapy Catapult (CGT Catapult) has published new data in their 2021 Cell and Gene Therapy GMP manufacturing report and 2021 UK cell and gene therapy skills demand report. These reports highlight the continued growth across the UK’s Advanced Therapy Medicinal Product (ATMP) manufacturing capacity and… Read More
Nykode Therapeutics (formerly Vaccibody) has entered into a license and collaboration agreement with Regeneron for the discovery, development and commercialisation of potential new vaccines for cancer and infectious diseases. What is the structure of the agreement? The agreement includes five programmes, three within cancer and two within infectious diseases. Read More
Researchers at the Francis Crick Institute and Universidade de Santiago de Compostela have identified how the hepatitis B virus (HBV) can support the survival and growth of liver cancer, with this process starting early in tumour development, in some instances up to 20 years before cancer diagnosis. Context Around… Read More
Moderna has appointed Darius Hughes as UK General Manager in what the company considers an “important milestone” in its growth in the UK market. Background Hughes joins Moderna following eight years as the head of Pfizer’s UK vaccines business unit where most recently he liaised… Read More
Neurocrine Biosciences and Sosei Group Corporation have collaborated to develop novel muscarinic receptor agonists, which Neurocrine Biosciences intends to study in the treatment for schizophrenia, dementia and other neuropsychiatric disorders. The agreement terms Under the terms of the agreement, Neurocrine Biosciences gains development and commercialisation rights to… Read More
A free webinar, Sensitive signature peptide quantification using accurate mass spectrometry, was hosted by DDW on December 1, 2021, at 4PM GMT, 9AM PT; 12PM ET; 5PM CET. It was supported by SCIEX. Emerging advancements in protein biotherapeutics are driving the… Read More
Listen to this article on the DDW Podcast: As part of the Fall Issue of DDW's Market Report, Dr Henry Li, CSO, Crown Bioscience examines cycles of innovation in the Chinese life sciences industry and how they provide opportunities for global drug discovery breakthroughs. Drug research and development in China has changed… Read More
PerkinElmer has launched the PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor PerkinElmer instruments and workflows in real-time. The PKeye Workflow Monitor informs users of the start, stop and completion of operations. It can also notify users if manual intervention is needed, such as the… Read More
Listen to this article on the DDW Podcast: In the second part of this series helping researchers determine whether a LIMs or an ELN is right for them, Barry Bunin, CEO Collaborative Drug Discovery, continues his guide to understanding what a LIMS is and how it differs from other scientific data management systems. Read… Read More
News round-up by DDW’s Megan Thomas for 22-26 November As the year draws to a close, looking both back and forward to identify and anticipate trends and market behaviour is important. This week, DDW’s Megan Thomas has rounded up five stories which identify interesting and impactful trends and analysis with… Read More
This is the latest episode of the free DDW podcast, “Building on current drug discovery methods”. It covers two narrated article written for Volume 22, Issue 2 – Spring 2021 of DDW and read aloud by Megan Thomas. The articles are called “The new synthesis: How synthetic DNA technology is… Read More
This is the latest episode of the free narrated DDW podcast, “Building on current drug discovery methods”. It covers two narrated articles written for Volume 22, Issue 2 – Spring 2021 of DDW and read aloud by Megan Thomas. The articles are called “The… Read More
